This slide demonstrates the immense market size. Again, if...

This slide demonstrates the immense market size.

Again, if toying with any of the other platforms in existence for finding worldwide clinical trials, they do a terrible job at satisfying a customer's search queries/ needs.

The thing that excites me here is that Opyl possesses the marketing knowledge required to drive patients to their platform at a low cost per patient (i.e. via their paid social media marketing channels/ expertise), and simultaneously have the ability to then convert these customers through a site that offers a better user experience. When you consider those + the 44bn USD market they're operating within, the current, low, 15mln AUD valuation is unbelievably low.